These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18691272)

  • 1. Prevalence of low male testosterone levels in primary care in Germany: cross-sectional results from the DETECT study.
    Schneider HJ; Sievers C; Klotsche J; Böhler S; Pittrow D; Lehnert H; Wittchen HU; Stalla GK
    Clin Endocrinol (Oxf); 2009 Mar; 70(3):446-54. PubMed ID: 18691272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of hypogonadism in males aged at least 45 years: the HIM study.
    Mulligan T; Frick MF; Zuraw QC; Stemhagen A; McWhirter C
    Int J Clin Pract; 2006 Jul; 60(7):762-9. PubMed ID: 16846397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testosterone levels in men with erectile dysfunction.
    Martínez-Jabaloyas JM; Queipo-Zaragozá A; Pastor-Hernández F; Gil-Salom M; Chuan-Nuez P
    BJU Int; 2006 Jun; 97(6):1278-83. PubMed ID: 16686726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity.
    Kapoor D; Aldred H; Clark S; Channer KS; Jones TH
    Diabetes Care; 2007 Apr; 30(4):911-7. PubMed ID: 17392552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypogonadism in male patients with cancer.
    Garcia JM; Li H; Mann D; Epner D; Hayes TG; Marcelli M; Cunningham GR
    Cancer; 2006 Jun; 106(12):2583-91. PubMed ID: 16688773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychobiologic correlates of the metabolic syndrome and associated sexual dysfunction.
    Corona G; Mannucci E; Schulman C; Petrone L; Mansani R; Cilotti A; Balercia G; Chiarini V; Forti G; Maggi M
    Eur Urol; 2006 Sep; 50(3):595-604; discussion 604. PubMed ID: 16564129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of androgen deficiency in men with erectile dysfunction.
    Köhler TS; Kim J; Feia K; Bodie J; Johnson N; Makhlouf A; Monga M
    Urology; 2008 Apr; 71(4):693-7. PubMed ID: 18313109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
    Fiuza M; Cortez-Dias N; Martins S; Belo A;
    Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity and abdominal obesity; an alarming challenge for cardio-metabolic risk in Turkish adults.
    Oğuz A; Temizhan A; Abaci A; Kozan O; Erol C; Ongen Z; Celik S
    Anadolu Kardiyol Derg; 2008 Dec; 8(6):401-6. PubMed ID: 19103534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome: prevalence, associated factors, and C-reactive protein: the MADRIC (MADrid RIesgo Cardiovascular) Study.
    Martínez MA; Puig JG; Mora M; Aragón R; O'Dogherty P; Antón JL; Sánchez-Villares T; Rubio JM; Rosado J; Torres R; Marcos J; Pallardo LF; Banegas JR;
    Metabolism; 2008 Sep; 57(9):1232-40. PubMed ID: 18702949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of metabolic syndrome according to Adult Treatment Panel III and International Diabetes Federation criteria: a population-based study.
    Bener A; Zirie M; Musallam M; Khader YS; Al-Hamaq AO
    Metab Syndr Relat Disord; 2009 Jun; 7(3):221-9. PubMed ID: 19320557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone replacement therapy for late-onset hypogonadism.
    Cunningham GR
    Nat Clin Pract Urol; 2006 May; 3(5):260-7. PubMed ID: 16691239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology: testosterone and the metabolic syndrome.
    Svartberg J
    Int J Impot Res; 2007; 19(2):124-8. PubMed ID: 16858366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
    Coward RM; Simhan J; Carson CC
    BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypogonadism is associated with overt depression symptoms in men with erectile dysfunction.
    Makhlouf AA; Mohamed MA; Seftel AD; Niederberger C
    Int J Impot Res; 2008; 20(2):157-61. PubMed ID: 17703222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between simultaneous PSA and serum testosterone concentrations among eugonadal, untreated hypogonadal and hypogonadal men receiving testosterone replacement therapy.
    Grober ED; Lamb DJ; Khera M; Murthy L; Lipshultz LI
    Int J Impot Res; 2008; 20(6):561-5. PubMed ID: 18843272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypogonadism and diabetes.
    Betancourt-Albrecht M; Cunningham GR
    Int J Impot Res; 2003 Aug; 15 Suppl 4():S14-20. PubMed ID: 12934046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
    Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
    Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypogonadism and subnormal total testosterone levels in men with type 2 diabetes mellitus.
    Ogbera OA; Sonny C; Olufemi F; Wale A
    J Coll Physicians Surg Pak; 2011 Sep; 21(9):517-21. PubMed ID: 21914405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypogonadotropic hypogonadism in men with type 2 diabetes.
    Dandona P; Dhindsa S; Chandel A; Chaudhuri A
    Postgrad Med; 2009 May; 121(3):45-51. PubMed ID: 19491539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.